Kezar Life Sciences Inc Share Price

NASDAQ: KZR

Small Cap

$3.86

-0.09

(-2.34%)

as on September 16, 2025 at 1:22 am IST

$₹

Kezar Life Sciences Inc Stock Performance

as on September 16, 2025 at 1:22 am IST

Day's Low
Day's High
$3.85
Day's Price Range
$4.05
$3.86
0.26%
Downside
4.92%
Upside
52 Week's Low
52 Week's High
$3.62
52-Week Price Range
$9.18
$3.86
6.22%
Downside
137.82%
Upside

Kezar Life Sciences Inc share price movements today

Previous Close: $3.95
Open: $4.05
Volume: 204.3K
Day's Low - High: $3.85 - $4.05
52 Week Low - High: $3.62 - $9.18

Kezar Life Sciences Inc Historical Returns

1 Month Return: -0.5 %
3 Month Return: -13.94 %
1 Year Return: -30.7 %
3 Year Return: -95.98 %
5 Year Return: -91.96 %

Kezar Life Sciences Inc Stock Fundamentals & Key Indicators

Check Kezar Life Sciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.9M

EPS (TTM)

-7.5333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-74.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

870900.00%

Kezar Life Sciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kezar Life Sciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kezar Life Sciences Inc	BUY	$28.9M	-91.96%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Kezar Life Sciences Inc Stock including INR - Dollar returns

The Kezar Life Sciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Kezar Life Sciences Inc investment value today

Current value as on today

₹72,705

Returns

₹27,295

(-27.3%)

Returns from Kezar Life Sciences Inc Stock

₹32,281 (-32.28%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Kezar Life Sciences Inc Stock

Based on 10 analysts

BUY

60.00%

Buy

40.00%

Hold

0.00%

Sell

Based on 10 analysts, 60% of analysts recommend a 'BUY' rating for Kezar Life Sciences Inc. Average target price of $12.5

Kezar Life Sciences Inc Share Price Target

Get share price movements and forecasts by analysts on Kezar Life Sciences Inc.

What analysts predicted

69.12%UPSIDE

Target Price

$12.5

Current Price

$3.86

Analyzed by

10 Analysts

Target

$12.50

Kezar Life Sciences Inc target price $12.5, a slight upside of 69.12% compared to current price of $3.86. According to 10 analysts rating.

Kezar Life Sciences Inc Stock's Interest Amongst Investors

Search interest for Kezar Life Sciences Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:20% versus previous 30 day period

Kezar Life Sciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	7	-5	-	-	-	1	-	-
Gross Profit	0	0	6	0	0	0	0	0	0	-
Operating Income	-24	-26	-25	-28	-23	-23	-21	-21	-17	-14
EBITDA	-21	-23	-22	-31	-20	-20	-19	-19	-15	-14
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-22	-24	-23	-32	-21	-21	-20	-20	-16	-13
Income Tax Expense	-1	2	0	0	0	-	-	0	-	-
Net Income	-20	-24	-23	-32	-21	-21	-20	-20	-16	-13
Net Profit Margin	0.00%	0.00%	-330.04%	594.33%	0.00%	0.00%	0.00%	-1940.31%	0.00%	0.00%

Kezar Life Sciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	7	-
Gross Profit	0	0	0	-1	-1	-1	-1	5	-1
Operating Income	-8	-8	-24	-37	-42	-54	-71	-105	-90
EBITDA	-8	-8	-24	-36	-41	-52	-70	-99	-81
Interest Expense	-	-	-	-	1	0	1	1	1
Depreciation	-	0	0	1	1	1	1	0	1
Income Before Tax	-8	-8	-23	-35	-41	-54	-68	-101	-83
Income Tax Expense	-	-	1	-3	-2	-1	-2	0	-
Net Income	-8	-8	-23	-31	-38	-54	-65	-101	-83
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1455.29%	0.00%

Kezar Life Sciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-24	-23	-32	-21	-21	-20	-20	-16	-13
Operating Cash Flow	-21	-20	-18	-22	-17	-17	-16	-17	-12
Investing Cash Flow	13	18	27	20	12	24	23	13	11
Financing Cash Flow	0	0	0	-	0	-	0	-1	-1
Change in Cash	-8	-1	8	-2	-4	6	6	-4	-2

Kezar Life Sciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-8	-23	-35	-41	-54	-68	-101	-83
Operating Cash Flow	-8	-20	-29	-36	-42	-58	-81	-74
Investing Cash Flow	0	-83	20	-56	-28	-91	76	80
Financing Cash Flow	49	77	0	99	112	127	0	0
Change in Cash	41	-26	-9	6	41	-22	-4	6

Global Institutional Holdings in Kezar Life Sciences Inc

Funds	Holdings
TANG CAPITAL MANAGEMENT LLC	9.86%
Suvretta Capital Management, LLC	9.81%
Avidity Partners Management LP	6.88%
BML Capital Management LLC	5.59%
Vanguard Group Inc	3.78%

See all

Insights on Kezar Life Sciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 103.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 118.7% return, outperforming this stock by 214.4%
NEGATIVE IMPACT
Price Dip
In the last 6 months, KZR stock has moved down by -32.7%

About Kezar Life Sciences Inc

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california.

Organisation	Kezar Life Sciences Inc
Headquarters	4000 Shoreline Court, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Dr. Christopher J. Kirk Ph.D.
E-voting on shares	Click here to vote

Key Management of Kezar Life Sciences Inc

Name	Title
Mr. Mark Schiller	Chief Operations Officer
Dr. Jack Taunton Ph.D.	Co-Founder
Ms. Pattie Chiang	Principal Accounting Officer, Senior VP & Corporate Controller
Dr. Neel K. Anand Ph.D.	Senior Vice President of Research & Drug Discovery
Mr. Zung To	Chief Development Officer
Dr. Christopher J. Kirk Ph.D.	Co-Founder, CEO & Director
Mr. John Franklin Fowler	Co-Founder & Director
Mr. Marc L. Belsky CPA	CFO & Secretary
Ms. Gitanjali Jain	Senior Vice President of Investor Relations & External Affairs
Mr. Joe Tedrick	Vice President of Human Resources

FAQs

What is Kezar Life Sciences Inc share price today?

Kezar Life Sciences Inc share price today is $3.86 as on September 16, 2025 at 1:22 am IST at the close of the market. Kezar Life Sciences Inc share today touched a day high of $4.05 and a low of $3.85.

What is the 52 week high and 52 week low for Kezar Life Sciences Inc share?

Kezar Life Sciences Inc share touched a 52 week high of $9.18 on October 9, 2024 and a 52 week low of $3.62 on April 4, 2025. Kezar Life Sciences Inc stock price today i.e. September 16, 2025 at 1:22 am IST is closed at $3.86,which is 57.95% down from its 52 week high and 6.63% up from its 52 week low.

What is Kezar Life Sciences Inc's market capitalisation today?

Kezar Life Sciences Inc market capitalisation is $0.00T as on September 16, 2025 at 1:22 am IST.

How to invest in Kezar Life Sciences Inc Stock (KZR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kezar Life Sciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kezar Life Sciences Inc Shares that will get you 0.3886 shares as per Kezar Life Sciences Inc share price of $3.86 per share as on September 16, 2025 at 1:22 am IST.

What is the minimum amount required to buy Kezar Life Sciences Inc Stock (KZR) from India?

Indian investors can start investing in Kezar Life Sciences Inc (KZR) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Kezar Life Sciences Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 10:43 am IST). Based on Kezar Life Sciences Inc share’s latest price of $3.86 as on September 16, 2025 at 1:22 am IST, you will get 2.5907 shares of Kezar Life Sciences Inc. Learn more about fractional shares .

What are the returns that Kezar Life Sciences Inc has given to Indian investors in the last 5 years?

Kezar Life Sciences Inc stock has given -91.96% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?